First-in-child use of the oral soluble guanylate cyclase stimulator riociguat in pulmonary arterial hypertension.
about
First-in-child use of the oral soluble guanylate cyclase stimulator riociguat in pulmonary arterial hypertension.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
First-in-child use of the oral ...... lmonary arterial hypertension.
@en
First-in-child use of the oral ...... lmonary arterial hypertension.
@nl
type
label
First-in-child use of the oral ...... lmonary arterial hypertension.
@en
First-in-child use of the oral ...... lmonary arterial hypertension.
@nl
prefLabel
First-in-child use of the oral ...... lmonary arterial hypertension.
@en
First-in-child use of the oral ...... lmonary arterial hypertension.
@nl
P2093
P2860
P356
P1476
First-in-child use of the oral ...... lmonary arterial hypertension.
@en
P2093
Christoph M Happel
Georg Hansmann
Harald Bertram
Rainer Kozlik-Feldmann
Till Spreemann
P2860
P304
2045893217743123
P356
10.1177/2045893217743123
P577
2017-01-01T00:00:00Z